This genetic model of SSc is characterized by hyperplasia of the sub-cutaneous loose connective tissue with abnormal dermis, osteopenia and deregulation of the interleukin-4 (IL4)/IL4 receptor (IL4R) signaling pathway. This evidence concerns the gene IL4 and Osteopenia.